您现在的位置是:首页 》 发表论文

浏览论文(根据年份):
All
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Before 2006
授权专利(12项目):
详细

2007  (1 / Total 98 )

  • 1
    Liu S, Hsieh W, Jiang Y, Kim Y, Sreerama S, Chen X, Jia B, Wang F. Evaluation of a 99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin αvβ3-positive Breast Cancer. Bioconjugate Chem. 2007, 18(2):438-446.

    Integrin αvβ3 plays a critical role in tumor angiogenesis and metastasis. Radiolabeled RGD peptides that are integrin αvβ3-specific are very useful for noninvasive imaging of integrin expression in rapidly growing and metastatic tumors. In this study, we determined the binding affinity of E{E[c(RGDfK)]2}2 (tetramer) and its 6-hydrazinonicotinamide conjugate (HYNIC-tetramer) against the binding of 125I-echistatin to the integrin αvβ3-positive MDA-MB-435 breast cancer cells. The athymic nude mice bearing MDA-MB-435 xenografts were used to evaluate the potential of ternary ligand complex [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] (TPPTS = trisodium triphenylphosphine-3,3‘,3‘ ‘-trisulfonate) as a new radiotracer for imaging breast cancer integrin αvβ3 expression by single photon emission computed tomography (SPECT). It was found that the binding affinity of tetramer (IC50 = 51 ± 11 nM) was slightly higher than that of its dimeric analogue (IC50 = 78 ± 27 nM) and is comparable to that of the HYNIC-tetramer conjugate (IC50 = 55 ± 11 nM) within the experimental error. Biodistribution data showed that [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] had a rapid blood clearance (4.61 ± 0.81 %ID/g at 5 min postinjection (p.i.) and 0.56 ± 0.12 %ID/g at 120 min p.i.) and was excreted mainly via the renal route. [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] had high tumor uptake with a long tumor retention (5.60 ± 0.87 %ID/g and 7.30 ± 1.32 %ID/g at 5 and 120 min p.i., respectively). The integrin αvβ3-specificity was demonstrated by co-injection of excess E[c(RGDfK)]2, which resulted in a significant reduction in tumor uptake of the radiotracer. The metabolic stability of [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] was determined by analyzing urine and feces samples from the tumor-bearing mice at 120 min p.i. In the urine, about 20% of [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] remained intact while only ∼15% metabolized species was detected in feces. SPECT images displayed significant radiotracer localization in tumor with good contrast as early as 1 h p.i. The high tumor uptake and fast renal excretion make [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] a promising radiotracer for noninvasive imaging of the integrin αvβ3-positive tumors by SPECT.http://dx.doi.org/10.1021/bc0603081


中心地址:北京市海淀区学院路38号  电话:010-82802871  传真:010-82801145    邮编:100191
Copyright(C)2017北京大学医学同位素研究中心 All right reserved